WPWilliam P. Potsic

William P. Potsic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


William P. Potsic has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Ralph F. Wetmore

    3 shared publications
  • Daniel S. Samadi

    2 shared publications
  • Gail J. Anderson

    Department of Otolaryngology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia

    1 shared publication
  • Joel W. Goldwein

    Division of Radiation Oncology, Hospital of the University of Pennsylvania and the University of Pennsylvania School of Medicine, Philadelphia

    1 shared publication
  • Lawrence W. C. Tom

    Department of Otolaryngology, Children's Hospital of Philadelphia, PA 19104

    1 shared publication
  • Richard B. Womer

    Department of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia

    1 shared publication

Latest Publications

  • Open Access

    A Staging System for Congenital Cholesteatoma

    by William P. Potsic, Daniel S. Samadi, Roger R. Marsh, Ralph F. Wetmore

    THE CLASSIC presentation of congenital cholesteatoma is as a pearl behind an intact tympanic membrane in the anterior-superior quadrant, but congenital cholesteatoma can present elsewhere in the middle ear, can erode ossicles, and may extend to the mastoid. The extent of disease greatly affects the likelihood that residual cholesteatoma will remain after surgery. If one is to make comparisons among practices or to evaluate one's own experience, it is necessary to adjust for severity of disease. Analyzing the case mix is essential to evaluating outcomes.


  • Congenital cholesteatoma: 20 years' experience at The Children's Hospital of Philadelphia

    by William P. Potsic, S. Bruce Korman, Daniel S. Samadi, Ralph F. Wetmore

    OBJECTIVE: We report our experience with congenital cholesteatoma over a span of 20 years with an emphasis on presenting characteristics and predictors of outcome.METHODS: We conducted a retrospective review from 1981 through 2000.RESULTS: One hundred seventy‐two congenital cases were identified in 167 patients. Five patients had bilateral disease. The majority (72%) were found in boys, with an average age of 5.0 years. Hearing loss was slight to moderate. When confined to 1 quadrant, cholesteatoma was anterosuperior in 82% of cases; 47% had cholesteatoma in 2 or more quadrants. Ossicular chain involvement was found in 43% of all cases, and mastoid extension was evident in 23%. The rate of recurrent disease was directly related to the extent and number of quadrants involved.CONCLUSION: To our knowledge, this is the largest series of congenital cholesteatomas to be reported. This review confirms the male predominance and predilection for the anterosuperior quadrant. The extent of cholesteatoma and its relation to residual disease should be used as a guide for planning a second‐look procedure.


  • Open Access

    Nasopharyngeal malignancies in children

    by Lawrence W. C. Tom, Gail J. Anderson, Richard B. Womer, Ralph F. Wetmore, Steven D. Handler, William P. Potsic, Joel W. Goldwein

    A retrospective analysis identified 29 children with nasopharyngeal malignancies who were evaluated at the Children's Hospital of Philadelphia from 1970 through 1989. Rhabdomyosarcoma (15) and carcinoma (9) were the most common tumor types, and there were distinct differences in the clinical presentations of these two malignancies. Patients with rhabdomyosarcoma were generally younger than those with carcinoma and enjoyed longer survival. Six (67%) of the children with carcinoma were black; all of the patients with rhabdomyosarcoma were white. Patients with carcinoma were also more likely to present with cervical metastases. The presentation, evaluation, and methods of treatment for pediatric nasopharyngeal malignancies are discussed.